Benzyl chloroformate → Benzyl (3-fluoropiperidin-4-yl)carbamate
反応式
C([NH:8][C@H:9]1[CH2:14][CH2:13][N:12](C(OC(C)(C)C)=O)[CH2:11][C@H:10]1[F:22])C1C=CC=CC=1.Cl[C:24]([O:26][CH2:27][C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1)=[O:25]>C(O)C.[OH-].[OH-].[Pd+2]>[CH2:27]([O:26][C:24]([NH:8][CH:9]1[CH2:14][CH2:13][NH:12][CH2:11][CH:10]1[F:22])=[O:25])[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1参加物
実験手順
cis-(+)-4-Benzylamino-1-tert-butoxycarbonyl-3-fluoropiperidine [Enantiomer 1] (15.0 g, 0.049 mole) in ethanol (300 ml) was hydrogenated over 20% palladium hydroxide on carbon (4 g) at 30 psi for 5 h, then filtered through celite and evaporated. The crude amine was dissolved in ethyl acetate (100 mL), saturated sodium hydrogen carbonate solution (100 mL) was added followed by benzyl chloroformate (7.6 mL, 0.53 mole) and the mixture stirred vigorously for 4 h. The organic phase was separated dried and evaporated. The product was dissolved in DCM (75 mL) and stirred with TFA (20 mL) for 4 h then evaporated. The residue was basified with sodium carbonate solution, extracted with 10% methanol in DCM and the extracts dried and evaporated to give a white solid (12.1 g, 98%), [α]D+61.10 (MeOH).
後処理
- filtrationfiltered through celite
- customevaporated
- dissolutionThe crude amine was dissolved in ethyl acetate (100 mL)
- additionsaturated sodium hydrogen carbonate solution (100 mL) was added
- customThe organic phase was separated
- customdried
- customevaporated
- dissolutionThe product was dissolved in DCM (75 mL)
- stirringstirred with TFA (20 mL) for 4 h
- customthen evaporated
- extractionextracted with 10% methanol in DCM
- customthe extracts dried
- customevaporated
出典と根拠
- ORDレコード
- ord-3f93811877c04631998a52e2bd240f88
- 出典データセット
- uspto-grants-2007_12
- 特許番号
- US07312212B2
反応ノート
読み込み中…